Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

Children, the weight issue and how we deal with this responsibly?

Say Communication, Healthcare PR Agency, looks at how children deal with the weight issue and how we can approach it responsibly.

Say Communications

Longevity but at what price?

Say Communications, healthcare PR agency, analyses the prospect of living to 150 years old, thanks to the anti-ageing biomedical research, and what PR will look like.

Say Communications

- PMLiVE

Novartis bags EU approvals for three ex-GSK drugs

Revolade, Tafinlar and Mekinist all receive regulatory approval

- PMLiVE

Industry files complaint against France’s off-label law

Protests against promotion of Roche's Avastin as cheap eye medication

- PMLiVE

Alnylam predicts big things for its PCSK9 inhibitor ALN-PCS

Genesilencing specialist says its early-stage candidate has blockbuster potential

Sanofi and Google partner on digital health in diabetes

Aimto develop new patient tools by harnessing data and miniaturised tech

Bayer symbol

Bayer moves heart failure candidate finerenone into phase III

Follows positive phase IIb data presented at the European Society of Cardiology(ESC) meeting

- PMLiVE

Roche wins first approval for skin cancer drug Cotellic

Swissregulators give the Exelixis-discovered treatment the green light

- PMLiVE

GCI Health expands into medical education

Commsagency appoints Cally Clarkson to lead its new offering in thearea

- PMLiVE

Dr Reddy’s makes senior changes as US generics head exits

UmangVohra will be replaced by Alok Sonig

CytomX appoints Rachel Humphrey chief medical officer

Former VP of Eli Lilly and AstraZeneca joins the company

Daiichi Sankyo logo

NICE recommends Daiichi Sankyo’s Lixiana for DVT and PE

Institute's final guidance concludes the novel oral anticoagulant is cost effective

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links